Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

Trump’s U-Turn on Nvidia Chip Sales Fuels Talk of US-China ‘Grand Bargain’ on Tech and Trade

by Team Lumida
July 18, 2025
in Markets
Reading Time: 4 mins read
A A
0
How Nvidia’s AI Chips are Secretly Making Their Way to China

Source: Ars Technicia

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  1. Export Controls Eased: The Trump administration has reversed course, allowing Nvidia and AMD to resume sales of less advanced AI chips (like Nvidia’s H20) to China, signaling a shift from the previous “maximum restriction” approach.
  2. Strategic Rationale: Commerce Secretary Howard Lutnick said the goal is to keep Chinese developers “addicted” to U.S. technology, maintaining U.S. leverage while still restricting China’s access to the most advanced chips.
  3. Potential Grand Bargain: Analysts see this as a possible opening for a broader US-China tech and trade deal, with bargaining chips including semiconductors, rare earths, battery tech, and mutual market access.
  4. Diplomatic Thaw: The move follows recent diplomatic engagement and a truce that saw the U.S. lower tariffs and ease some export controls in exchange for Chinese rare-earth magnets, with more talks and possible deals expected ahead of a Trump-Xi summit.
  5. Transactional Approach: Trump’s strategy is less ideologically rigid than Biden’s, focusing on transactional deals to secure U.S. economic interests, including large Chinese purchases of U.S. goods and action on fentanyl precursors.

What Happened?

In a major policy reversal, the Trump administration has told Nvidia and AMD they can resume sales of certain AI chips to China, after previously imposing strict export controls to maintain a U.S. tech lead. The administration’s new approach aims to keep China reliant on U.S. technology while still protecting the most sensitive advances.

This shift comes as the U.S. and China are engaged in renewed trade and tech talks, with both sides signaling willingness to negotiate on a range of issues—from tariffs and rare earths to investment restrictions and the future of TikTok’s U.S. operations.


Why It Matters?

The decision marks a significant softening in U.S. tech policy toward China and could pave the way for a broader “grand bargain” on trade and technology. By balancing export controls with continued market access, the U.S. hopes to maintain leverage over China’s tech sector while reducing the risk of full economic decoupling.

The move also reflects Trump’s pragmatic, deal-oriented approach, which could lead to further concessions and agreements as both sides prepare for a possible leaders’ summit later this year.


What’s Next?

Expect further negotiations between U.S. and Chinese officials, with the potential for incremental deals on tariffs, tech exports, and market access. The outcome of these talks will shape the future of U.S.-China economic relations and the global tech supply chain, especially as both sides seek to avoid escalation and find common ground.

Investors and industry players will be watching for signs of additional policy shifts, new export licenses, and the broader impact on U.S. chipmakers and global tech competition.

Source
Previous Post

Meta Hires Top Apple AI Researchers, Escalating Talent War in Silicon Valley

Next Post

Wells Fargo Suspends China Travel After Banker Blocked From Leaving Country

Recommended For You

Google Bets on California Consolidation to Win the AI Race — Appointing Kavukcuoglu as Hassabis Steps Back, as Researchers Flee to Rivals and Jeff Dean Launches Startup

by Team Lumida
15 hours ago
Alphabet $GOOGL Q2 2024 Results

Google is concentrating its AI leadership in Mountain View, appointing Koray Kavukcuoglu — mentored by Yann LeCun, now the only remaining Gemini co-lead — to run its sprawling...

Read more

Aschenbrenner Returns to Investing With $400 Million Private Bet Days After SA Nearly Collapsed — Got Married Mid-Crisis to Anthropic CEO’s Chief of Staff

by Team Lumida
15 hours ago
Leopold Aschenbrenner’s Situational Awareness Fund Down 67% in July — Citadel Steps In to Buy the AI Stock Portfolio

Leopold Aschenbrenner made a $400 million investment in an undisclosed private company on Tuesday — just days after Situational Awareness nearly buckled under margin calls that collapsed its...

Read more

SoftBank Piles On: $10 Billion Margin Loan Backed by OpenAI Stake Brings Total OpenAI Exposure to ~$65 Billion by October

by Team Lumida
15 hours ago
SoftBank’s Narrow Gain: How AI Investments Shape the Future

SoftBank secured a $10 billion two-year margin loan from Goldman Sachs, JPMorgan, Mizuho, Apollo, and SMBC backed by its OpenAI preferred share stake — adding to the $40...

Read more

The A-List Behind Situational Awareness — D1’s Sundheim, Greenoaks’ Mehta, and Tiger Global’s Dewan Backed a 20-Something With No Track Record on the AI Trade

by Team Lumida
2 days ago
Leopold Aschenbrenner’s Situational Awareness Fund Down 67% in July — Citadel Steps In to Buy the AI Stock Portfolio

WSJ reveals the elite investor roster behind Situational Awareness — the AI hedge fund that lost ~67% in July — which was backed by D1 Capital's Dan Sundheim,...

Read more

SpaceX Spent $15.8 Billion on AI in One Quarter — Doubled Its Prior Spend and Is Just Getting Started

by Team Lumida
2 days ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

SpaceX reported $18.4 billion in total Q2 capital expenditures, with $15.8 billion tied specifically to its AI build-out — double the prior quarter — as Elon Musk's rocket...

Read more

Citadel Buys Situational Awareness Public Equities at 10% Discount, Triggering Relief Rally as Fund Assets Collapse From $45B to $10B

by Team Lumida
2 days ago
Ken Griffin Warns Trump-Era Political вмешening Is Distorting Corporate Decision-Making

Ken Griffin's Citadel purchased Situational Awareness's public equity portfolio at a 10% discount, triggering a relief rally across SA's former holdings as the fund's assets collapsed from $45...

Read more

Caterpillar Surges 11% as Data Center Power Demand Drives Record $72 Billion Backlog — AI Infrastructure Is Now CAT’s Biggest Business

by Team Lumida
2 days ago
a bulldozer in a dirt field

Caterpillar crushed Q2 estimates — $8.17 EPS vs. $6.17 expected, $20.5B revenue vs. $19B expected — as its power and energy unit, which makes generators and turbines for...

Read more

Apple’s Worst Day Since Tariffs, Microsoft’s Best Day Ever — Big Tech Earnings Split the Market as New Fed Chair Leaves Investors “Doved and Confused”

by Team Lumida
4 days ago
close-up photo of monitor displaying graph

A week of blockbuster tech earnings sent stocks sharply in opposite directions: Microsoft notched the largest single-session market cap gain in US history while Apple suffered its worst...

Read more

AstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined RevenueAstraZenecaAstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined Revenue

by Team Lumida
4 days ago
vitamin b 12 100 mg

AstraZeneca has held early-stage talks with Bristol-Myers Squibb about a potential combination that would create the world's largest drugmaker — a deal analysts say would be hard to...

Read more

Morgan Stanley Upgrades Korea to Overweight, Sees 36% Upside — “Leverage Washout” Creates Entry Point Into AI and Industrial Super-Cycle

by Team Lumida
4 days ago
Morgan Stanley Q2 2024 Earnings Summary

Morgan Stanley upgraded the Kospi to overweight with a 9,000 target — 36% above current levels — arguing that the index's 30%+ selloff from its June peak reflects...

Read more
Next Post
Wells Fargo Analysts Reveal Stock Market Winners for the Next 18 Months

Wells Fargo Suspends China Travel After Banker Blocked From Leaving Country

Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

SEC Considers ‘Innovation Exception’ to Spur Tokenization After Landmark Stablecoin Bill Passes

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Why U.S. Data Center Power is Set to Skyrocket by 2027

Why U.S. Data Center Power is Set to Skyrocket by 2027

September 24, 2024
Is BlackRock the New Leader in Alternative Investments?

BlackRock Pauses Fundraising for Asia Private Credit Fund Amid HPS Merger

August 25, 2025
Adobe’s AI Challenges: Stock Drops on Weak 2024 Outlook

Adobe Raises Fiscal 2025 Outlook as AI Tools Like Firefly Drive Growth

June 13, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018